{"id":452425,"date":"2021-03-08T07:33:19","date_gmt":"2021-03-08T12:33:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452425"},"modified":"2021-03-08T07:33:19","modified_gmt":"2021-03-08T12:33:19","slug":"miravo-healthcare-announces-2020-and-fourth-quarter-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-announces-2020-and-fourth-quarter-results\/","title":{"rendered":"Miravo Healthcare\u2122 Announces 2020 and Fourth Quarter Results"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n –<\/span>
\n <\/i>
\n \u00a0<\/i>
\n Fiscal Year 2020 Adjusted Total Revenue – $71.0 million<\/span> –<\/i>
\n
\n
\n –<\/span>
\n <\/i>
\n \u00a0<\/i>
\n Fiscal Year 2020 Adjusted EBITDA – $28.4 million<\/span> –<\/i>
\n
\n
\n –<\/span>
\n <\/i>
\n \u00a0Blexten Canadian Prescriptions Increased 35% Year-Over-Year –<\/i>
\n
\n
\n –<\/span>
\n <\/i>
\n \u00a0<\/i>
\n Cambia Canadian Prescriptions Increased 17% Year-Over-Year –<\/i>\n <\/p>\n

\n
\n Miravo to Host Conference Call\/Audio Webcast March 8th<\/span> at 11:00 a.m. ET<\/span><\/i>
\n <\/b>\n <\/p>\n

\n MISSISSAUGA, ON<\/span>, March 8, 2021<\/span> \/PRNewswire\/ –\u00a0Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d\/b\/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three months and year ended December 31<\/span>, 2020.\u00a0 For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Consolidated Financial Statements for the three months and year ended December 31, 2020<\/span> which are available on the Company’s website (www.miravohealthcare.com<\/a>).\u00a0 All figures are in Canadian dollars, unless otherwise noted.<\/p>\n

\n

\n
\n \"Miravo
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Key Developments<\/b>\n <\/p>\n